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Abstract 
Salbutamol, a 132 adrenergic agonist, has been shown to reduce carcass fat and increase 
muscle mass and improve feed conversion efficiency in pigs. In the present study, the 
effects of dietary salbutamol at 20 ppm on growth, feed conversion efficiency, carcass 
recovery, visceral organ weight, and whole carcass composition of rainbow trout 
(Oncorhynchus mykiss) were studied. Rainbow trout (eighteen months old; average 
initial weight 324.0±0.4 g) were fed either the control or control + 20 ppm salbutamol 
diet for four weeks in a completely randomized design. Fish were weighed at the start 
and termination of the study, and records of feed intake were maintained. Carcasses were 
analyzed for protein, fat and ash at the start and completion of the four weeks feeding 
period. Dietary salbutamol had no adverse effect on fish mortality, health or feed intake. 
Dietary salbutamol had no effect (p>0.10) on growth, feed intake or feed conversion 
efficiency of rainbow trout. Internal organ weights such as liver, heart, gonads and 
viscera-somatic index and hepato-somatic index were also not affected (p>0.10) by 
dietary salbutamol. Interestingly, kidney weight was significantly (p<0.01) increased by 
salbutamol. However, it is unlikely that salbutamol directly increased the kidney weight. 
Increased metabolic load on kidney and blood flow to the kidney could be reasons for 
increased kidney weight. Although the final weight and the growth rate were not affected 
by salbutamol, the carcass recovery was significantly higher (p<0.01) in salbutamol 
treated trout. Whole carcass protein content of both treated and control fish showed no 
significant differences and clearly reflected the normal allometric growth and body 
composition. It was concluded that dietary salbutamol at 20 ppm level had no 
repartitioning effect in growing rainbow trout. The effects of salbutamol at various doses 
in more mature rainbow trout need to be studied in future studies. 
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1. INTRODUCTION 
Fish as food makes a very significant contribution to human nutrition and health. 
Although relatively unimportant as a source of energy, fish is a palatable, convenient, 
and still moderately priced source of high quality protein, vitamins, minerals, micro-
nutrients and essential fatty acids (EFA). Particularly, the low fat nature of fish and the 
presence of EF A eicosapentaenoic acid (EPA, C20: 5n-3) and docosahexonoic acid 
(DHA,C22:6n-3) which are essential to human health (Bjerve 1987) make it a highly 
desirable food. The essentiality of n-3 unsaturated fatty acids found in fish and 
consumers search for diversity and improved nutritional quality of food have led to an 
increased demand for seafood. 
International trade in fish is increasing, driven by employment and the need to earn 
foreign exchange. In 1992, a total of 17 million tons of fish and fish products , valued at 
US$40.3 billion entered the international market. The share of developing countries has 
risen rapidly and currently exceeds 50% of the world catch. Either directly or indirectly 
fisheries , support about 200 million people, mostly in developing countries. 
Demand for seafood is steadily increasing, but wild fisheries have already reached their 
maximum exploitation (FAQ 1993). Aquaculture provides a promising alternative to 
this ever rising world demand for fish. During the last two decades aquaculture has 
grown rapidly and FAO (1999) predicted that by the year 2000, aquaculture will 
account for approximately 25% of world fisheries production. More than 220 aquatic 
species are farmed, ranging from giant clams which obtain most of nutrients from 
symbiotic algae, mussels which filter plankton, herbivorous carps to carnivorous salmon 
(FAQ 1999). 
Aquaculture on world-wide basis is now a profitable but competitive animal production 
industry (Lovell 1991). High growth rates and low recurrent costs determine the 
productivity and the profitability of the operation. In intensive aquaculture systems 
such as salmon and trout farming, feed costs can be as high as 60% of the recurrent cost. 
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Therefore, in aquaculture, high growth rate and efficient feed utilisation by fish is of 
paramount importance in increasing productivity and profitability. 
Efficient feed conversion indirectly helps to reduce the depletion of wild fisheries stocks 
used in feeds for the aquaculture industry. Production of a kilogram of rainbow trout uses 
about 2.46 kg of wild fish as fish meal or fish oil (Naylor et al., 2000). In 1997 more than 
10,000 metric tones of wild fish were used to feed the most commonly farmed fish. Hunter 
and Roberts (2000) predicted that 20-25% of the total fish meal production will be used in 
the aquaculture industry in 2000. Therefore ways of improving feed conversion efficiency 
are important to reduce the use of fish meal and fish oil for aquaculture feeds. 
Aquaculture industries are under increasing pressure to reduce the level of solid and 
dissolved wastes discharged to the environment (Mayer and McLean, 1995). Increased 
feed conversion efficiency helps to reduce the waste disposal by reducing level of 
phosphorous and nitrogenous compounds released to the environment. Increasing 
environmental concerns by consumers has made it imperative to produce fish sustainably. 
Various technologies have been used to increase the growth rate, feed efficiency and 
carcass composition mainly in terrestrial farm animals. Use of anabolic steroids, although 
proven to be successful, has already been banned in almost every country. Breeding and 
selection for the above parameters will be slow for already highly selected breeds and may 
only be possible with unselected wild stocks. Although the prospects of improvement 
through genetic engineering is promising, apart from the associated high cost, increasing 
public concern over genetic modification justifies the search for alternative approaches to 
improve production. Somatotropins modify the carcass composition by increasing protein 
content and reducing fat content while increasing the feed conversion efficiency. The 
major draw-back of somatotropins is that they have to be administrated by injection or by 
implantation devices. Immersion techniques have not been successfully used in 
commercial situations. 
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During the last 15 years 13 adrenergic agonists have been extensively studied as potential 
candidates for manipulating growth and carcass composition mainly in terrestrial animals. 
It is generally accepted that some 13 agonists change the carcass composition by increasing 
the skeletal muscle protein content while reducing fat content. In some cases, the growth 
and feed conversion efficiency have also improved. Since these compounds redirect the 
nutrients away from adipose tissues towards skeletal muscle hypertrophy, they are 
generally termed as repartitioning agents. The major advantage of 13 adrenergic agonists is 
that, compared to somatotropins, 13 adrenergic agonists are orally active and therefore can 
be given with feeds. A variety of 13 adrenergic agonists such as cimaterol, clenbuterol, 
ractopamine, L644,969 and salbutamol have been studied in various terrestrial farm 
animals and laboratory animals. Until recently use of 13 agonists for food animal production 
had been banned. Now two 13 agonists, namely ractopamine and zilpaterol, have been 
cleared for food animal industries in several countries, including the USA. 
Although 13 agonists have been extensively studied in terrestrial animals, they have been 
less extensively studied in fish. The first such study was reported in 1992. Two 13 agonists, 
namely, ractopamine and L644, 969 have been studied in rainbow trout and channel catfish. 
Available literature suggests that dietary 13 agonists are not as effective in fish as in 
terrestrial animals. Of the fish species studied, channel catfish have found to be more 
sensitive to dietary 13 agonists. Salbutamol is a selective 132 agonist and has found to be 
effective in pigs. The present study investigated the effects of feeding salbutamol at 20 
ppm on the growth performance, body composition and the organ weight in young rainbow 
trout (Oncorhynchus mykiss). 
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